Metraipolis › archive › dc_65482f39c0ae
CDK4/6 inhibitors rechallenge post-progression in HR-positive HER2-negative advanced/metastatic breast cancer patients: a meta-analysis of… — Europe PMC PMID:42192452
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42192452
- DOI
- 10.1186/s13058-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:41:05.266Z
- SHA-256 of the archived text
905ca48adbc19974ead0cba5317299f7efb47731ccd04e930bfa03aa965ebbf7- Stable URL of this page
https://metraipolis.com/documento/dc_65482f39c0ae
How to cite
CDK4/6 inhibitors rechallenge post-progression in HR-positive HER2-negative advanced/metastatic breast cancer patients: a meta-analysis of… — Europe PMC PMID:42192452 — Europe PMC (en), https://europepmc.org/article/MED/42192452 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_65482f39c0ae (Metraipolis archive dc_65482f39c0ae, sha256 905ca48adbc19974ead0cba5317299f7efb47731ccd04e930bfa03aa965ebbf7)
BibTeX
@misc{dc65482f39c0ae,
title = {CDK4/6 inhibitors rechallenge post-progression in HR-positive HER2-negative advanced/metastatic breast cancer patients: a meta-analysis of… — Europe PMC PMID:42192452},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42192452},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_65482f39c0ae; sha256 905ca48adbc19974ead0cba5317299f7efb47731ccd04e930bfa03aa965ebbf7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192452. Agents can read the archived copy with the MCP tool read_document.